Evaluation of the Efficacy, Safety, and Tolerability of LevoCept (NCT04457076)

🧪 Interventions in This Study

• LevoCept (DRUG)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (27 Sites)

Showing the first 25 of 27 sites.

• Essential Access Health-Berkeley — Berkeley, California
• Essential Access Health-Los Angeles — Los Angeles, California
• University of California Davis Health System Department of Obstetrics and Gynecology — Sacramento, California
• WR-Medical Center for Clinical Research — San Diego, California
• Women's Health Care Research — San Diego, California
• Stanford University, Medical Center, Obstetrics and Gynecolocy — Stanford, California
• University Of Colorado Department of Obstetrics & Gyncology — Aurora, Colorado
• Emory University School of Medicine Gynecology/Obstetrics — Atlanta, Georgia
• Soapstone Center for Clinical Research — Decatur, Georgia
• University of Hawaii — Honolulu, Hawaii
• IU Health University Hospital — Indianapolis, Indiana
• Planned Parenthood North Central States — Minneapolis, Minnesota
• Planned Parenthood of the St. Louis Region and Southwest Missouri — Manchester, Missouri
• Rex Garn Mabey Jr., MD — Las Vegas, Nevada
• Columbia University Medical Center — New York, New York
• University of Cincinnati/Reproductive Medicine Research — Cincinnati, Ohio
• Ohio State University — Columbus, Ohio
• The Ohio State University Ob/Gyn Research Office — Columbus, Ohio
• Oregon Health & Science University — Portland, Oregon
• Hospital of the University of Pennsylvania — Philadelphia, Pennsylvania
• Clinical Research of Philadelphia, LLC — Philadelphia, Pennsylvania
• Magee-Womens Hospital, Center for Family Planning Research — Pittsburgh, Pennsylvania
• Advances In Health — Houston, Texas
• University of Utah Healthcare Health Sciences Center — Salt Lake City, Utah
• Tidewater Physicians for Women — Norfolk, Virginia

📞 Contact the Study Coordinator

Phone: (213) 386-5614

Email: avankessel@essentialaccess.org

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Contraception

• Casea S Contraceptive Implants (Casea S) Trial — Santo Domingo, DN
• Family Planning Elevated: Initiative Evaluation — Salt Lake City, Utah
• Birth Control to Improve Birth Spacing — Boston, Massachusetts
• FemBloc® Permanent Contraception - Confirmation Feasibility Trial — Chandler, Arizona
• The Over The Counter Pill National Study — Portland, Oregon

Explore by condition: All Contraception clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Contact the study coordinator using the phone/email above.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.